<DOC>
	<DOCNO>NCT00019357</DOCNO>
	<brief_summary>RATIONALE : Interleukin-2 may stimulate person 's white blood cell kill tumor cell . Combining white blood cell , activate vaccine , interleukin-2 may kill cancer cell . PURPOSE : Phase I trial study effectiveness interleukin-2 plus activated white blood cell treat patient cancer respond chemotherapy radiation therapy .</brief_summary>
	<brief_title>Interleukin-2 Plus Activated White Blood Cells Treating Patients With Cancer That Has Not Responded Chemotherapy Radiation Therapy</brief_title>
	<detailed_description>OBJECTIVES : I . Determine feasibility expansion reinfusion specific T-cell line ( peptide-specific activate lymphocyte ) , combination interleukin-2 , patient vaccinate ras peptide . II . Assess immunologic status antitumor response may occur treatment patient . OUTLINE : Autologous peptide-specific activate lymphocyte ( PAL ) , previously harvest patient follow vaccination different protocol , expand reinfused intravenously ; follow 4 hour observation period . Patients receive interleukin-2 ( IL-2 ) administer subcutaneously 5 day week 2 week ; first dose IL-2 administer least 4 hour PAL infusion . Patients follow month 2 month treatment . PROJECTED ACCRUAL : A total 150 patient accrue study .</detailed_description>
	<mesh_term>Aldesleukin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Patients must enrol treat mutated ra peptide vaccine another protocol Malignant disease chemotherapy radiation option increase survival available No history CNS metastases PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 01 Life expectancy : Not specify Hematopoietic : Platelet count least 100,000/mm3 Hepatic : Bilirubin great 2 mg/dL SGOT SGPT great 4 time normal Renal : Creatinine great 2.0 mg/dL Cardiovascular : No active ischemic heart disease ( i.e. , NYHA class III IV cardiac disease ) No myocardial infarction within past 6 month No history congestive heart failure No ventricular arrhythmia arrhythmia require therapy Other : HIV negative No hepatitis B C infection No active infection require antibiotic No history autoimmune disease ( e.g. , autoimmune neutropenia , thrombocytopenia , hemolytic anemia ; systemic lupus erythematosus , Sjogren syndrome , scleroderma ; myasthenia gravis ; Goodpasture syndrome ; Addison 's disease , Hashimoto 's thyroiditis , active Graves ' disease ) No active second malignancy curatively treat carcinoma situ cervix basal cell carcinoma skin Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : At least 4 week since prior immunotherapy recover Chemotherapy : At least 4 week since prior chemotherapy recover Endocrine therapy : At least 4 week since prior steroid recover No concurrent steroid Radiotherapy : At least 4 week since prior radiotherapy recover Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2001</verification_date>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
</DOC>